期刊
FUTURE CARDIOLOGY
卷 14, 期 2, 页码 131-141出版社
FUTURE MEDICINE LTD
DOI: 10.2217/fca-2017-0074
关键词
BNP; cardiac biomarkers; cTnI; cTnT; electrochemical technique; multiplexed detection; near-patient test; point-of-care; rapid; zinc oxide nanostructure
资金
- Enlisense LLC
Aim: Development of a label-free multiplexed point-of-care diagnostic device for a panel of cardiac biomarkers - cardiac troponin-T (cTnT), troponin-I (cTnI) and B-type natriuretic peptide (BNP). Methods: A nonfaradaic electrochemical immunoassay designed with anisotropic high surface area ZnO nanostructures grown using low-temperature hydrothermal methods was selectively immobilized with capture antibodies. Multiplexed detection in human serum using ZnO nanostructures based on complementary electrochemical measurement techniques - electrochemical impedance spectroscopy and Mott-Schottky. Results: Linear signal response for detection of three biomarkers in human serum with dynamic range of 1 pg/ml-100 ng/ml and limit of detection at 1 pg/ml and low signal response to background interferences was achieved. Conclusion: First demonstration of simultaneous detection of three cardiac biomarkers in clinically relevant range with sensor's analytical performance and linear response of detection showed potential utility in screening clinical samples for early diagnosis of acute myocardial infarction and chronic heart failure.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据